Reply to: EEG-based model and antidepressant response
Nat Biotechnol
.
2021 Jan;39(1):28-29.
doi: 10.1038/s41587-020-0738-2.
Epub 2020 Dec 14.
Authors
Wei Wu
1
2
3
,
Diego A Pizzagall
4
,
Madhukar H Trivedi
5
6
,
Amit Etkin
7
8
9
Affiliations
1
Department of Psychiatry and Behavioral Sciences, Stanford University, Stanford, CA, USA.
2
Wu Tsai Neuroscience Institute, Stanford University, Stanford, CA, USA.
3
Alto Neuroscience, Inc., Los Altos, CA, USA.
4
Department of Psychiatry, Harvard Medical School and McLean Hospital, Belmont, MA, USA.
5
Department of Psychiatry, University of Texas Southwestern Medical Center, Dallas, TX, USA.
6
O'Donnell Brain Institute, University of Texas Southwestern Medical Center, Dallas, TX, USA.
7
Department of Psychiatry and Behavioral Sciences, Stanford University, Stanford, CA, USA. amitetkin@altoneuroscience.com.
8
Wu Tsai Neuroscience Institute, Stanford University, Stanford, CA, USA. amitetkin@altoneuroscience.com.
9
Alto Neuroscience, Inc., Los Altos, CA, USA. amitetkin@altoneuroscience.com.
PMID:
33318653
DOI:
10.1038/s41587-020-0738-2
No abstract available
Publication types
Letter
Comment
MeSH terms
Antidepressive Agents / therapeutic use
Depression / drug therapy
Depressive Disorder, Major* / drug therapy
Electroencephalography
Humans
Substances
Antidepressive Agents